Vertex passes key test in quest to treat kidney diseases
Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.
Latest articles, guides, and insights to help you succeed.
Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.
Restaurants in India are facing closure as the government restricts the supply of LPG as cooking fuel, industry representatives tell CNBC.
Saba, alongside Cox Capital Management, launched a tender offer to purchase shares in one of Blue Owl's non-traded private credit funds at a 34.9% discount.
A federal appeals court ordered the end to the SAVE plan, the Biden-administration era program used by millions of student loan borrowers.
Home sales made a small gain to start the year, but higher mortgage rates now could throw cold water on the spring season.
Chancellor keen to avoid costly intervention as concerns mount about economic impact of war in Middle East
"Beliefs peppered with self-criticism can tank motivation, but turning negative self-talk into more positive language can fuel tenacity," says Nir Eyal, author of "Beyond Belief."
President Donald Trump on Monday had predicted that the war against Iran would be over "very soon," and warned that country against withholding oil afterward.
The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.
U.S. oil prices are back below $90 a barrel, and a couple software stocks caught upgrades including Club name CrowdStrike.
A prolonged U.S.-Israel war against Iran could lead to shortages of key chipmaking materials and higher energy costs which could hurt semiconductor demand.
Also in today’s newsletter, the economies that will pay the biggest price for the conflict